Rapport Therapeutics, Inc.
RAPPFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Rapport Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Rapport Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-26 · Third Rock Ventures V, L.P.: Larger than 55 of the 61 other insider sales of Common Stock on file. SEC filing
- 2026-05-11 · Third Rock Ventures V, L.P.: Larger than 59 of the 61 other insider sales of Common Stock on file. SEC filing
- 2026-05-07 · Third Rock Ventures V, L.P.: Larger than 60 of the 61 other insider sales of Common Stock on file. SEC filing
- 2026-04-17 · Third Rock Ventures V, L.P.: Larger than all 61 other insider sales of Common Stock on file. SEC filing
- 2026-04-17 · Yeleswaram Krishnaswamy: Larger than 56 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-09-17 · Ceesay Abraham: Larger than 57 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-09-17 · Ceesay Abraham: Larger than 58 of the 61 other insider sales of Common Stock on file. SEC filing
- 2025-09-12 · PAUL STEVEN M: Larger than 22 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2024-06-10 · HEALY JAMES: Larger than 21 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2024-06-10 · HEALY JAMES: Larger than all 23 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-09-11–2025-09-12: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2025-03-12–2025-03-13: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-26 | Third Rock Ventures V, L.P. · 10% owner | Common Stock | S — Open market or private sale | −18,572 | 40.05 | SEC filing |
| 2026-05-11 | Third Rock Ventures V, L.P. · 10% owner | Common Stock | S — Open market or private sale | −133,618 | 40.24 | SEC filing |
| 2026-05-08 | Third Rock Ventures V, L.P. · 10% owner | Common Stock | S — Open market or private sale | −5,018 | 40.31 | SEC filing |
| 2026-05-07 | Third Rock Ventures V, L.P. · 10% owner | Common Stock | S — Open market or private sale | −271,495 | 40.12 | SEC filing |
| 2026-04-17 | Yeleswaram Krishnaswamy · Chief Development Officer | Common Stock | S — Open market or private sale | −20,225 | 39.99 | SEC filing |
| 2026-04-17 | Third Rock Ventures V, L.P. · 10% owner | Common Stock | S — Open market or private sale | −426,005 | 40.32 | SEC filing |
| 2026-04-14 | Yeleswaram Krishnaswamy · Chief Development Officer | Common Stock | S — Open market or private sale | −10,200 | 35.08 | SEC filing |
| 2026-04-13 | Yeleswaram Krishnaswamy · Chief Development Officer | Common Stock | S — Open market or private sale | −9,165 | 34.97 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-10 | HEALY JAMES · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | PAUL STEVEN M · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | Sanchez Ramiro · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | Young Wendy B. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | Huber Reid M · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | PEREZ ROBERT J · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | Silva Paul M · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
| 2026-06-10 | MARAGANORE JOHN · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,200 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.